Tempus AI stock crashed Tuesday as investors questioned the medical AI company's long-term growth prospects. But William Blair analyst Andrew Brackmann remains a believer in the stock. Tempus uses ...
Thomas Fuller / SOPA Images / LightRocket via Getty Images Tempus AI's fourth-quarter results missed estimates as its costs increased. The medical technology firm's non-GAAP operating expenses ...
Shares of Tempus AI (NASDAQ:TEM) dropped 19% Tuesday, the day after the AI-focused healthcare company released a Q4 earnings report that missed Street estimates and its 2025 financial forecast.
Tempus AI reports fourth-quarter revenue of $200.68 million, missing estimates of $203.12 million. Tempus reports a fourth-quarter adjusted loss of 18 cents per share, beating analyst estimates ...
Tempus AI stock faces mixed signals ahead of Q4 earnings, with short-term bearish pressure but technical support. Analysts see a 13.5% downside for Tempus AI, while technical indicators suggest ...